Morales G, Zavala C

Language: Spanish
References: 10
Page: 109-117
PDF size: 77.87 Kb.

ABSTRACT

The sclerosing cholangitis is a cholestasic chronic disease characterized by patched inflammation, fibrosis and stenosis. The primary is the most common. The severity varies from asymptomatic to biliary cirrhosis. The characteristic image in the biopsy is onion skin fibrosis.

REFERENCES

1. Feldman. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. 7th Ed. Elsevier 2002: 1131-1144.

2. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jamerson JL. Harrison’s Principles of Internal Medicine. 15 Ed. McGraw-Hill 2001: 1787.

3. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-33.

4. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Yawn BP, Dickson ER, Melton LJ. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-69.

5. Sherlock S. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis. Clin Liver Dis 2000; 4: 97-113.

6. Raj V, Lichtenstein DR. Hepatobiliary manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 491-511.

7. Balan V, LaRusso NF. Hepatobiliary disease of inflammatory bowel disease. Gastroenterol Clin North Am 1995; 24: 647-69.

8. Lindor KD. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336: 691-5.

9. Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999; 341: 1368-78.

10. Siqueira E, Schoen RE, Silverman W, Martini J, Rabinovitz M, Weissfeld JL, Elmaagd KA, Madariaga JR, Slivka A. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002; 56: 40-7.